1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Escalon Medical Corp.

Escalon Medical Corp.

ESMC
Escalon Medical Corp.US flagOther OTC
0.19
USD
- -
- -
1.41MMarket Cap
Escalon Medical Corp.
ESMC
(Other OTC)

Recent

price

0.19

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
4.2
3.4
1.52
1.53
1.64
1.75
1.54
1.49
1.51
1.3
1.27
1.41
1.44
1.64
1.62
1.62
1.54
Revenue per Share
-0.05
-0.76
-0.79
0.35
-0.05
-0.07
-0.15
-0.1
0.07
-0.04
-0.09
-0.01
- -
0.03
-0.02
- -
0.11
Basic EPS, GAAP
-0.09
-0.1
-0.1
-0.26
-0.09
-0.07
-0.17
-0.07
0.01
-0.07
-0.03
0.11
-0.14
0.04
-0.09
0.05
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-7.53
-8.29
-9.08
-8.73
-8.78
-8.85
-8.99
-9.07
-9
-9.2
-9.28
-9.29
-9.29
-9.23
-9.24
-9.23
-8.93
Book Value per Share
1.19
0.59
-0.01
0.41
0.36
0.3
0.13
0.05
0.13
0.1
0.1
0.1
0.1
0.16
0.15
0.17
0.47
Tangible Book Value per Share
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
Basic Weighted Avg Shares
32
26
11
11
12
13
12
11
11
10
9
10
11
12
12
12
11
Sales/Revenue/Turnover
-10.7
-15.47
-11.5
-10.71
-2.89
-8.01
-9.85
-4.47
1.8
-2.63
-8.45
-0.32
-4.39
3.93
-0.87
1.11
-7.82
Operating Margin (%)
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-6
-6
3
- -
-1
-1
-1
1
- -
-1
- -
- -
- -
- -
- -
2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-1.31
-22.51
-51.87
22.83
-3.09
-4.12
-9.95
-6.47
5.12
-2.6
-6.92
-0.5
0.17
3.75
-1.05
0.88
16.18
Profit Margin (%)
11
8
- -
4
4
3
2
1
2
2
1
1
1
2
2
2
4
Working Capital
3
5
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
- -
- -
1
LT Debt
12
6
1
4
3
3
2
1
2
2
2
1
1
2
2
2
4
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
8.67
- -
- -
- -
-15.37
17.23
- -
5.89
-23.26
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-1.05
- -
- -
- -
-0.05
-0.71
- -
-0.19
-2.84
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
1
Preferred Equity and Hybrid Capital
1
1
1
Shares Outstanding
7
7
7
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
4
4
7
Cash, Cash Equivalents & STI
1
- -
3
Accounts Receivable, Net
1
2
1
Inventories
2
2
2
Total Current Liabilities
3
3
3
Payables & Accruals
2
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.73%
5.61%
5.83%
Free Cash Flow
-221.84%
-256.95%
-158.6%
Net Income, GAAP
180.1%
377.63%
-184.24%
Sales/Revenue/Turnover
-0.49%
5.26%
0.54%
Total Cash Common Dividend
- -
65.51%
49.85%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3
3
3
3
12
2025
3
3
3
3
12
2026
3
4
3
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
-0.02
- -
-0.02
2025
-0.01
0.02
0.02
- -
- -
2026
-0.03
0.01
0.16
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Shenzhen Edge Medical Co Ltd (2675.HK)
EMVision Medical Devices Ltd (EMV.AX)
Electromed, Inc. (ELMD)
Respiri Limited (RSH.AX)
Taiwan Biomaterial Co., Ltd. (6649.TWO)
Shanghai Kinetic Medical Co., Ltd (300326.SZ)
Business
Escalon Medical Corp. (OTCQB: ESMC) operates in the healthcare market, specializing in the development, manufacture, marketing, and distribution of medical devices for ophthalmic applications; its core offerings include ophthalmic ultrasound systems such as A-Scans for internal eye structure analysis, B-Scans for diagnostic imaging in cloudy ocular media, high-frequency UBM devices for anterior segment evaluation, and Pachymeters for corneal thickness measurement; Ispan Intraocular Gases including C3F8 and SF6 for vitreoretinal tamponade in detached retina surgery; disposable surgical packs and universal gas kits for vitreoretinal procedures; AXIS image management systems for web-based handling of diagnostic images across devices; and digital photography, telemedicine, and PACS solutions under the Sonomed Escalon group, which encompasses wholly-owned subsidiaries Sonomed Inc. and Escalon Medical Imaging. The company serves medical institutions worldwide through independent sales representatives, distributors, and internal sales teams, with primary operations in the United States and international markets. Founded in 1987 and headquartered in Wayne, Pennsylvania, Escalon maintains manufacturing and operational facilities in Lake Success, New York; New Berlin, Wisconsin; and Stoneham, Massachusetts. The Sonomed Escalon group continues to lead in ophthalmic diagnostics imaging and surgical solutions, previously marketed under Sonomed, Escalon Digital Solutions, and Escalon/Trek Medical brands, with ongoing focus on product development, strategic partnerships, and acquisitions to expand its ophthalmic portfolio. Recent earnings for the first quarter ended September 30, 2025, reflect sustained operations in its core segments amid stable market conditions.

Company News

APIChatGPT

  • defenseworld.net

    Financial Analysis: Merit Medical Systems (NASDAQ:MMSI) & Escalon Medical (OTCMKTS:ESMC)

  • defenseworld.net

    Reviewing Remedent (OTCMKTS:REMI) and Escalon Medical (OTCMKTS:ESMC)